Huadong Medicine Co., Ltd (000963.SZ) announced earnings for its first quarter that Increased, from last year
The company's bottom line totaled RMB1.002 billion, or RMB0.5715 per share. This compares with RMB0.914 billion, or RMB0.5213 per share, last year.
The company's revenue for the period rose 4.2% to RMB11.183 billion from RMB10.735 billion last year.
Huadong Medicine Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB1.002 Bln. vs. RMB0.914 Bln. last year.-EPS: RMB0.5715 vs. RMB0.5213 last year.-Revenue: RMB11.183 Bln vs. RMB10.735 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.